201 related articles for article (PubMed ID: 10479297)
21. Phosphoryloxymethyl carbamates and carbonates--novel water-soluble prodrugs for amines and hindered alcohols.
Safadi M; Oliyai R; Stella VJ
Pharm Res; 1993 Sep; 10(9):1350-5. PubMed ID: 8234176
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of camptothecin and polymer-conjugated camptothecin in tumor spheroids and solid tumors.
Ying V; Haverstick K; Page RL; Saltzman WM
J Biomater Sci Polym Ed; 2007; 18(10):1283-99. PubMed ID: 17939886
[TBL] [Abstract][Full Text] [Related]
23. An unexpected amide bond cleavage: poly (ethylene glycol) transport forms of vancomycin. 2.
Greenwald RB; Zhao H; Peng P; Longley CB; Dai QH; Xia J; Martinez A
Eur J Med Chem; 2005 Aug; 40(8):798-804. PubMed ID: 16122582
[TBL] [Abstract][Full Text] [Related]
24. Comparison of half-lives and cytotoxicity of N-chloroethyl-4-amino and N-mesyloxyethyl-benzoyl compounds, products of prodrugs in antibody-directed enzyme prodrug therapy (ADEPT).
Springer CJ; Antoniw P; Bagshawe KD; Wilman DE
Anticancer Drug Des; 1991 Nov; 6(5):467-79. PubMed ID: 1764165
[TBL] [Abstract][Full Text] [Related]
25. N-Monosubstituted Methoxy-oligo(ethylene glycol) Carbamate Ester Prodrugs of Resveratrol.
Mattarei A; Azzolini M; Zoratti M; Biasutto L; Paradisi C
Molecules; 2015 Sep; 20(9):16085-102. PubMed ID: 26404221
[TBL] [Abstract][Full Text] [Related]
26. Poly(ethylene glycol) anticancer drug delivery systems.
Greenwald RB
P R Health Sci J; 2002 Jun; 21(2):113-21. PubMed ID: 12166021
[No Abstract] [Full Text] [Related]
27. Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs.
Pettit GR; Lippert JW
Anticancer Drug Des; 2000 Jun; 15(3):203-16. PubMed ID: 11049088
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatins.
Ohsumi K; Hatanaka T; Nakagawa R; Fukuda Y; Morinaga Y; Suga Y; Nihei Y; Ohishi K; Akiyama Y; Tsuji T
Anticancer Drug Des; 1999 Dec; 14(6):539-48. PubMed ID: 10834274
[TBL] [Abstract][Full Text] [Related]
29. Combination cancer therapy by hapten-targeted prodrug-activating enzymes and cytokines.
Chuang KH; Cheng CM; Roffler SR; Lu YL; Lin SR; Wang JY; Tzou WS; Su YC; Chen BM; Cheng TL
Bioconjug Chem; 2006; 17(3):707-14. PubMed ID: 16704208
[TBL] [Abstract][Full Text] [Related]
30. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
31. PEG-Ara-C conjugates for controlled release.
Schiavon O; Pasut G; Moro S; Orsolini P; Guiotto A; Veronese FM
Eur J Med Chem; 2004 Feb; 39(2):123-33. PubMed ID: 14987821
[TBL] [Abstract][Full Text] [Related]
32. Camptothecin delivery systems: the antitumor activity of a camptothecin-20-0-polyethylene glycol ester transport form.
Conover CD; Pendri A; Lee C; Gilbert CW; Shum KL; Greenwald RB
Anticancer Res; 1997; 17(5A):3361-8. PubMed ID: 9413173
[TBL] [Abstract][Full Text] [Related]
33. Metalloprotease-specific poly(ethylene glycol) methyl ether-peptide-doxorubicin conjugate for targeting anticancer drug delivery based on angiogenesis.
Bae M; Cho S; Song J; Lee GY; Kim K; Yang J; Cho K; Kim SY; Byun Y
Drugs Exp Clin Res; 2003; 29(1):15-23. PubMed ID: 12866360
[TBL] [Abstract][Full Text] [Related]
34. Reversible pegylation of insulin facilitates its prolonged action in vivo.
Shechter Y; Mironchik M; Rubinraut S; Tsubery H; Sasson K; Marcus Y; Fridkin M
Eur J Pharm Biopharm; 2008 Sep; 70(1):19-28. PubMed ID: 18495444
[TBL] [Abstract][Full Text] [Related]
35. Avidin-biotin-PEG-CPA complexes as potential EPR-directed therapeutic protein carriers: preparation and characterization.
Ke S; Wright JC; Kwon GS
Bioconjug Chem; 2007; 18(5):1644-50. PubMed ID: 17705554
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of self-immolative glucuronide-based prodrugs of a phenol mustard.
Lougerstay-Madec R; Florent JC; Monneret C; Nemati F; Poupon MF
Anticancer Drug Des; 1998 Dec; 13(8):995-1007. PubMed ID: 10335272
[TBL] [Abstract][Full Text] [Related]
37. Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide.
Fang J; Sawa T; Akaike T; Maeda H
Cancer Res; 2002 Jun; 62(11):3138-43. PubMed ID: 12036926
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase.
Hay MP; Atwell GJ; Wilson WR; Pullen SM; Denny WA
J Med Chem; 2003 Jun; 46(12):2456-66. PubMed ID: 12773049
[TBL] [Abstract][Full Text] [Related]
40. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]